Do patients with migraine and obesity receive different treatments? Insights from real-world data.

ABSTRACT:

Background

Patients with obesity often experience stigma in healthcare, which may lead to underdiagnosis or undertreatment. In the context of pain management, and migraine specifically, patients with obesity are more likely to receive both opioid and non-opioid analgesics. However, little is known about their use of preventive treatments.

Methods

We conducted a large retrospective cohort study using propensity score matching for sex and age, utilizing data from the Clalit Health Services database in Israel. The study compared newly diagnosed patients with migraine with and without obesity, identified between June 2020 and June 2023. The comparison focused on prescriptions for migraine-specific acute medication (triptans) and preventive migraine treatments.

Results

Our

SUBMITTER: Pardo K 

PROVIDER: S-EPMC12849530 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature